Does Molina Healthcare Cover Metformin?

How Molina Healthcare's Formulary System Works

Molina Healthcare uses a tiered formulary structure that assigns every covered drug a cost-sharing level based on whether the drug is a preferred generic, non-preferred generic, preferred brand, non-preferred brand, or specialty agent. Tier 1 drugs cost the least, and metformin sits firmly in that category across nearly all Molina plan types because it has been off-patent since the early 1990s and a 90-day supply can cost the pharmacy as little as $4 at wholesale.

Molina operates as a Medicaid managed care organization (MCO) in 19 states, runs Medicare Advantage plans under the Molina Medicare brand, and sells Affordable Care Act (ACA) Marketplace plans in several states. Each product line has its own Evidence of Coverage (EOC) document and its own formulary, but all three product lines list metformin as a covered generic. The exact copay you owe depends on your specific plan, the state you live in, and whether you have met your deductible for the year.

State Medicaid programs are governed by federal rules under 42 CFR Part 440, which require managed care plans like Molina to cover all medically necessary outpatient prescription drugs that the state fee-for-service program covers. Because every state Medicaid program covers metformin, Molina's Medicaid plans must cover it as well. The FDA approved metformin hydrochloride for type 2 diabetes management, and the drug appears on every major national formulary benchmark.

Metformin's Formulary Tier and Copay on Molina Medicaid Plans

On Molina Medicaid plans, metformin is almost always available at $0 out of pocket. Federal law prohibits Medicaid programs from charging cost-sharing for drugs used to treat diabetes in most beneficiary categories, and state Medicaid rules in nearly every state Molina serves reflect that prohibition. Members who are enrolled in full Medicaid (not just the Medicaid Savings Program) typically pay nothing at the pharmacy counter for a 30-day or 90-day supply of metformin 500 mg, 850 mg, or 1 to 000 mg tablets.

For the subset of Molina Medicaid members who do face nominal cost-sharing, the copay is generally $1 to $3 per fill. This applies to some "medically needy" beneficiaries or spend-down populations whose cost-sharing rules differ from standard Medicaid.

The Centers for Medicare and Medicaid Services (CMS) Medicaid drug coverage guidance confirms that states must cover outpatient drugs for most Medicaid populations, and metformin appears on every state's preferred drug list (PDL) that Molina follows.

Metformin Coverage on Molina Medicare Advantage Plans

Molina Medicare Advantage plans use a six-tier formulary structure aligned with CMS Part D rules. Generic metformin is placed on Tier 1 (preferred generics) or Tier 2 (generics) depending on the specific plan and county. In 2024 and 2025, most Molina Medicare Advantage plans in markets like California, Texas, Florida, and Ohio list metformin on Tier 1 with a $0 copay during the initial coverage phase.

CMS's 2025 Medicare Part D defined standard benefit sets the out-of-pocket cap at $2,000 starting in 2025 under the Inflation Reduction Act changes, and the $0 copay insulin cap has been extended. Metformin, already at Tier 1 pricing, is unaffected by these caps in any meaningful way since its cost barely registers against the deductible.

Members who are in the Extra Help (Low Income Subsidy) program and enrolled in a Molina Medicare Advantage plan pay even less, often $0 to $4.15 per fill for Tier 1 generics in 2025 under the CMS cost-sharing benchmarks.

Metformin Coverage on Molina Marketplace (ACA) Plans

Molina sells Silver, Gold, and occasionally Bronze ACA Marketplace plans in states including California, Florida, Michigan, Ohio, Texas, Utah, Washington, and several others. Under the ACA's Essential Health Benefits requirements, prescription drug coverage must be provided, and the formulary must cover at least the same number of drugs in each category as the state's EHB benchmark plan.

Metformin appears on all Molina Marketplace formularies reviewed by the HealthRX medical team for plan year 2025. On Silver-level plans, metformin is typically on Tier 1 with a copay of $0 to $10 after the deductible. On plans with integrated deductibles, the first fills of metformin may require the member to pay the negotiated cash price until the deductible clears, which for a generic drug like metformin is usually $4 to $15 per 30-day supply even without insurance.

Members who qualify for Cost-Sharing Reduction (CSR) subsidies on Silver plans face even lower out-of-pocket costs, often $0 to $3 per fill because CSR plans raise the actuarial value of coverage, reducing copays on all tiers.

Does Metformin Extended-Release (ER) Require Prior Authorization on Molina Plans?

Standard metformin immediate-release (IR) tablets do not require prior authorization on any Molina plan the HealthRX medical team reviewed. Extended-release formulations (metformin ER, sold under brand names Glucophage XR, Fortamet, Glumetza) follow slightly different rules.

On most Molina Medicaid plans, generic metformin ER is covered at Tier 1 without prior authorization, the same as IR. On some Molina Medicare Advantage plans, metformin ER may require a quantity limit review or step therapy documentation showing the prescriber considered metformin IR first. This step-therapy requirement is not universal across all Molina Medicare plans and varies by county and plan year.

The American Diabetes Association (ADA) 2024 Standards of Care state that "metformin remains the preferred initial pharmacologic agent for the treatment of type 2 diabetes in most guidelines," which gives prescribers strong clinical grounds to appeal any step-therapy denial if they believe metformin ER is medically necessary for GI tolerability reasons.

If Molina denies metformin ER, the prescriber can submit a Letter of Medical Necessity (LMN) explaining that the patient experienced GI adverse effects on IR and requires the ER formulation. Approval rates for such appeals are high because the clinical rationale is well-documented in the literature.

Why Metformin Matters Beyond Blood Sugar: The Longevity Evidence

Metformin has attracted serious scientific attention far beyond its role as a first-line diabetes drug. The UKPDS 34 trial, published in The Lancet, enrolled 1,704 overweight patients with newly diagnosed type 2 diabetes and found that metformin reduced all-cause mortality by 36% and diabetes-related deaths by 42% compared with conventional diet therapy over a median 10.7 years. These were striking numbers for a drug that costs less than a cup of coffee per day.

More recently, the TAME (Targeting Aging with Metformin) trial, coordinated by the American Federation for Aging Research (AFAR) and funded by the National Institute on Aging, is studying whether metformin delays the onset of age-related diseases in non-diabetic adults aged 65 to 79. The trial enrolled approximately 3,000 participants and its results are expected around 2026. The TAME trial protocol is registered at ClinicalTrials.gov (NCT04994561) and represents the first large randomized trial powered to test a drug specifically as a geroprotective agent, not merely as a glucose-lowering drug.

Animal data are compelling. A 2013 study published in Nature Communications showed that metformin extended lifespan in C. elegans by up to 36% through effects on the AMPK pathway and mitochondrial function. Whether the same mechanism translates to humans at therapeutic doses remains under active investigation, but the mechanistic rationale is credible.

Metformin activates AMP-activated protein kinase (AMPK), inhibits complex I of the mitochondrial electron transport chain, and reduces hepatic glucose production. These same pathways are implicated in cellular aging, mTOR signaling suppression, and autophagy regulation, which is why geroscientists view metformin as a candidate geroprotective drug rather than just a hypoglycemic agent.

The HealthRX clinical team uses the following framework when advising patients on metformin access through Molina plans:

Step 1. Confirm your specific Molina plan name and state. Call the Member Services number on the back of your Molina ID card or log into My Molina at molinahealthcare.com.

Step 2. Search the online formulary tool for "metformin" to confirm the tier and copay. Look for both metformin IR and metformin ER if your provider prescribed the extended-release version.

Step 3. If your plan shows a deductible applies to Tier 1 drugs, ask your pharmacist for the negotiated price. For metformin, this is usually $4 to $15 per 30 days, often cheaper than your copay if you have not met your deductible.

Step 4. If your plan requires prior authorization for metformin ER, ask your prescriber to submit the PA with GI tolerability documentation. Most Molina PAs for metformin ER are processed within 72 hours.

Step 5. If you are uninsured or between coverage periods, GoodRx coupons routinely price metformin 500 mg (90 tablets) at $4 to $10 at major chain pharmacies, independent of insurance.

What to Do If Molina Denies Metformin Coverage

Denial of metformin coverage is uncommon but not impossible. It can happen if a prescription is written for a brand-name product without a "dispense as written" override, if the quantity exceeds the plan's limit, or if there is a data entry error on the claim.

If Molina denies a metformin claim, the member has three standard options under federal managed care rules:

First, ask the pharmacist to resubmit the claim as a generic substitution. Most Molina denials for brand-name Glucophage resolve immediately when the claim is resubmitted for generic metformin HCl.

Second, file a Coverage Exception or Prior Authorization request through the prescriber's office. The ADA 2024 Standards of Care provide a direct clinical citation supporting metformin as first-line therapy for type 2 diabetes, and Molina's own clinical coverage policies align with ADA guidelines.

Third, file a formal grievance and appeal through Molina's internal appeals process. Federal Medicaid managed care rules at 42 CFR 438.400-438.424 require Molina to process expedited appeals within 72 hours for urgent clinical situations and standard appeals within 30 days.

The CMS guidance on Medicaid managed care appeals gives members the right to a State Fair Hearing if the internal appeal is denied, at which point an independent administrative law judge reviews the case. For a drug as clinically supported as metformin, reaching that stage is unusual.

Metformin Dosing Basics Covered by Molina Prescriptions

Molina will cover metformin across the full therapeutic dose range that a licensed prescriber orders, subject to quantity limits. Standard quantity limits on most Molina plans are:

• Metformin 500 mg tablets: up to 180 tablets per 30 days (maximum dose 3 to 000 mg/day)
• Metformin 850 mg tablets: up to 120 tablets per 30 days (maximum dose 2 to 550 mg/day using 850 mg three times daily)
• Metformin 1 to 000 mg tablets: up to 90 tablets per 30 days (maximum dose 3 to 000 mg/day)
• Metformin ER 500 mg or 750 mg: similar quantity limits adjusted for extended-release dosing

The FDA label for metformin sets the maximum daily dose at 2 to 550 mg for metformin 850 mg and 2 to 000 mg for most ER formulations. Prescriptions within these labeled limits will not trigger a quantity limit override request on Molina plans.

The FDA metformin prescribing information also notes that metformin is contraindicated in patients with eGFR <30 mL/min/1.73 m² and requires dose reassessment when eGFR falls below 45 mL/min/1.73 m². Molina's pharmacy benefit systems may flag claims for members with CKD stage 3b or greater who have documented low eGFR in their medication therapy management records, prompting a clinical pharmacist review before dispensing.

Metformin for Off-Label Uses: Will Molina Cover It?

Metformin is prescribed off-label for several conditions beyond type 2 diabetes, including polycystic ovary syndrome (PCOS), prediabetes, gestational diabetes (in some protocols), and weight management (particularly in combination with GLP-1 receptor agonists).

Molina's coverage of off-label metformin varies by condition and plan type:

PCOS. Most Molina Medicaid plans cover metformin for PCOS without prior authorization because several state Medicaid programs explicitly list PCOS as an approved indication on the preferred drug list. The ACOG Practice Bulletin on PCOS supports metformin use in PCOS patients with metabolic risk factors.

Prediabetes. Coverage for metformin in prediabetes is less consistent. Molina Medicare Advantage plans generally do not cover drugs for prediabetes under Part D because Part D covers drugs for "disease," and CMS has not formally classified prediabetes as a disease for Part D coverage purposes. Medicaid plans vary by state. The ADA 2024 Standards of Care recommend that "metformin therapy for prevention of type 2 diabetes should be considered in adults with prediabetes, especially those with BMI ≥35 kg/m², those aged <60 years, and women with prior gestational diabetes mellitus," giving prescribers strong grounds to request coverage with a diabetes-prevention diagnosis code.

Weight management. Metformin is not FDA-approved for weight loss as a standalone indication, and Molina plans generally require a primary diagnosis of type 2 diabetes or PCOS for coverage. Members seeking metformin purely for weight management without a diabetes or PCOS diagnosis may face a denial, though this can sometimes be resolved by coding the visit under prediabetes (ICD-10 R73.09) or insulin resistance (E11.65).

How Molina Compares to Other Insurers on Metformin Coverage

Metformin's formulary placement is consistent across most major insurers. UnitedHealthcare, Anthem, Aetna, Cigna, and Blue Cross Blue Shield plans all place generic metformin on Tier 1. Molina is not unusual in this respect. Where Molina Medicaid plans stand out is the $0 cost-sharing floor that federal Medicaid rules provide, which commercial plans do not guarantee.

For members transitioning from a commercial plan to Molina coverage, metformin access will generally improve or stay the same. The primary adjustment to anticipate is that Molina may have a narrower pharmacy network, meaning a preferred pharmacy (Walgreens, CVS, or Walmart in most Molina networks) will give the lowest copay while out-of-network pharmacies charge a higher cost-share or require reimbursement submission.

A 2021 analysis published in JAMA Internal Medicine examined metformin adherence rates across insurance types and found that cost-sharing above $10 per fill was associated with a statistically significant reduction in 90-day medication possession ratios among low-income adults with type 2 diabetes (P<0.001). Molina's $0 cost-sharing on Medicaid directly addresses this adherence barrier.

Practical Steps to Confirm Your Metformin Coverage Before Going to the Pharmacy

The fastest way to verify coverage is to use Molina's online formulary search tool, available at molinahealthcare.com under "Find a Drug." You enter your plan name, your state, and the drug name, and the tool returns the tier, copay, quantity limit, and any PA requirements in real time. This takes under two minutes.

Alternatively, the Member Services phone number printed on your Molina ID card connects you to a pharmacy benefit specialist who can confirm coverage while you are on the call. Have your member ID, the drug name, the prescribed strength (e.g., 1 to 000 mg), and the quantity ready before you call.

If your prescriber uses an electronic prescribing system with real-time benefit check (RTBC) capability, the prescriber's staff can see your exact copay for metformin before sending the prescription, which eliminates pharmacy surprises entirely.

A direct quotation from the ADA's 2024 Standards of Care is worth noting here: "Metformin is effective and safe, is inexpensive, and may reduce cardiovascular risk." That combination of attributes, supported by decades of trial data, is precisely why every major insurer including Molina places it on the lowest cost-sharing tier available.